New Delhi: In a strategic move aimed at accelerating its growth and impact, Guttify, India’s first diagnosis-led gut health brand from LifeChart, has announced the appointment of Prashant Pitti, Co-founder of EaseMyTrip, as a strategic advisor. The collaboration underscores Guttify’s commitment to transforming preventive healthcare in India through a science-backed, Ayurveda-inspired model.
Along with assuming an advisory role, Mr. Pitti has also made a strategic investment in Guttify, further reinforcing his faith in the brand’s vision. While the financial details of the investment remain undisclosed, the partnership reflects strong synergy between Guttify’s healthcare mission and Mr. Pitti’s experience in scaling high-impact ventures.
On joining the brand, Prashant Pitti, Co-founder, EaseMyTrip, shared, “I have great confidence in Guttify and its founders, especially Mukul, with his past success of Yolo Bus. I am sure Guttify & Lifechart would be the next Viome from Bharat. Their unique blend of Ayurveda and modern diagnostics with a smart business plan is exactly what India’s gut health segment needs. I am proud to support their mission and excited to see their impact grow.”
Guttify recently secured $360,000 in extended seed funding in May 2025, bringing its total funding to over $1 million. The fresh capital will be used to expand its at-home, diagnosis-first gut wellness offerings across urban and semi-urban markets in India.
Mukul Shah, Co-founder of Guttify, added, “Having Prashant onboard is a game-changer. His belief in our vision and experience in scaling ventures profitably will help us build India’s leading gut health ecosystem.”
Guttify is an integrative approach to gut health by merging Ayurvedic insights with modern diagnostic techniques and personalized wellness plans. The brand’s ambitious roadmap now gains further momentum with Pitti’s strategic involvement—aiming to evolve from early-stage innovation to IPO readiness.
